Innospec Inc (IOSP) financial statements: income statement, balance sheet and cash flow
Innospec Inc's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Innospec Inc reported revenue of $1.8B (-3.7% year on year) and net income of $116.6M (+227.5% year on year).
Income statement
Innospec Inc income statement, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Net sales
$1.8B
$1.8B
$1.9B
$2.0B
Cost of goods sold
($1.3B)
($1.3B)
($1.4B)
($1.4B)
Gross profit
$492.4M
$542.9M
$591.1M
$586.7M
Selling, general and administrative
($285.1M)
($314.0M)
($387.8M)
($360.7M)
Research and development
($51.0M)
($47.8M)
($41.7M)
($38.7M)
Adjustment to fair value of contingent consideration
$15.9M
($3.4M)
—
—
Restructuring charge
($900.0K)
—
—
$0
Impairment of property, plant and equipment
($22.9M)
—
—
—
Impairment of intangible assets
($19.1M)
—
—
$0
Profit on disposal of property, plant and equipment
$200.0K
—
—
—
Total operating expenses
($362.9M)
($365.0M)
($429.5M)
($399.4M)
Operating income
$129.5M
$177.9M
$161.6M
$187.3M
Other income/(expense), net
($600.0K)
$9.6M
$10.5M
($1.6M)
Pension scheme settlement charge
$0
($155.6M)
—
—
Interest income/(expense), net
$9.2M
$9.3M
$2.3M
($1.1M)
Income before income tax expense
$138.1M
$41.2M
$174.4M
$184.6M
Income tax expense
($21.5M)
($5.6M)
($35.3M)
($51.6M)
Net income
$116.6M
$35.6M
$139.1M
$133.0M
Basic
$4.69
$1.43
$5.60
$5.37
Diluted
$4.67
$1.42
$5.56
$5.32
Basic
24.9M
24.9M
24.9M
24.8M
Diluted
25.0M
25.1M
25.0M
25.0M
Innospec Inc income statement, quarters
Line item
Jun 30, 2026 · Q2
Mar 31, 2026 · Q1
Sep 30, 2025 · Q3
Jun 30, 2025 · Q2
Net sales
$491.4M
$453.2M
$441.9M
$439.7M
Cost of goods sold
($353.1M)
($329.7M)
($325.2M)
($316.5M)
Gross profit
$138.3M
$123.5M
$116.7M
$123.2M
Selling, general and administrative
($84.3M)
($78.5M)
($71.9M)
($74.6M)
Research and development
($14.2M)
($13.2M)
($13.7M)
($13.6M)
Adjustment to fair value of contingent consideration
($100.0K)
$4.7M
$17.7M
($800.0K)
Profit on disposal of property, plant and equipment
$0
$0
$0
$100.0K
Total operating expenses
($98.6M)
($87.0M)
($110.8M)
($88.9M)
Operating income
$39.7M
$36.5M
$5.9M
$34.3M
Other income/(expense), net
$1.1M
$2.6M
$3.4M
($5.1M)
Interest income, net
$800.0K
$800.0K
$2.2M
$2.7M
Income before income tax expense
$41.6M
$39.9M
$11.5M
$31.9M
Income tax expense
($10.4M)
($9.1M)
$1.4M
($8.4M)
Net income
$31.2M
$30.8M
$12.9M
$23.5M
Net income attributable to non-controlling interests
($400.0K)
($400.0K)
—
—
Net income attributable to Innospec
$30.8M
$30.4M
—
—
Basic
$1.25
$1.23
$0.52
$0.94
Diluted
$1.25
$1.22
$0.52
$0.94
Basic
24.6M
24.8M
24.8M
24.9M
Diluted
24.7M
24.8M
24.9M
25.0M
Balance sheet
Innospec Inc balance sheet, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Cash and cash equivalents
$292.5M
$289.2M
$203.7M
$147.1M
Trade and other accounts receivable (less allowances of $11.8 million and $11.9 million, respectively)
$342.3M
$341.7M
$359.8M
$334.6M
Finished goods
$226.3M
$197.9M
$215.7M
$259.3M
Raw materials
$103.0M
$103.1M
$84.4M
$113.8M
Total inventories
$329.3M
$301.0M
$300.1M
$373.1M
Prepaid expenses
$20.1M
$21.0M
$18.7M
$14.1M
Prepaid income taxes
$13.1M
$3.1M
$2.8M
$3.3M
Other current assets
$7.3M
$600.0K
$600.0K
$400.0K
Total current assets
$1.0B
$956.6M
$885.7M
$872.6M
Net property, plant and equipment
$286.1M
$269.7M
$268.3M
$220.9M
Operating leases right-of-use assets
$52.7M
$44.8M
$45.1M
$45.3M
Goodwill
$399.0M
$382.5M
$399.3M
$358.8M
Other intangible assets
$67.7M
$65.4M
$57.3M
$45.0M
Deferred tax assets
$13.6M
$9.4M
$10.4M
$5.9M
Pension asset
$0
$2.4M
$35.1M
$48.1M
Other non-current assets
$8.7M
$3.9M
$6.2M
$7.1M
Total assets
$1.8B
$1.7B
$1.7B
$1.6B
Accounts payable
$174.7M
$163.8M
$163.6M
$165.3M
Accrued liabilities
$152.3M
$169.1M
$185.9M
$202.9M
Current portion of operating lease liabilities
$15.9M
$13.9M
$13.6M
$13.9M
Current portion of plant closure provisions
$4.9M
$5.0M
$4.6M
$5.3M
Current portion of acquisition-related contingent consideration
$7.0M
—
—
—
Current portion of accrued income taxes
$5.3M
$19.6M
$2.6M
$18.4M
Total current liabilities
$360.1M
$371.4M
$371.5M
$405.8M
Operating lease liabilities, net of current portion
$36.8M
$31.0M
$31.6M
$31.4M
Plant closure provisions, net of current portion
$60.2M
$55.3M
$57.0M
$51.9M
Deferred tax liabilities
$19.1M
$23.5M
$33.5M
$26.2M
Pension liabilities and post-employment benefits
$13.2M
$13.1M
$13.3M
$12.2M
Acquisition-related contingent consideration
$1.3M
$20.1M
$23.4M
—
Other non-current liabilities
$8.8M
$4.2M
$2.3M
$1.4M
Total liabilities
$499.5M
$518.6M
$557.8M
$563.3M
Common stock, $0.01 par value, authorized 40,000,000 shares, issued 29,554,500 shares
300.0K
300.0K
300.0K
300.0K
Additional paid-in capital
$376.5M
$369.9M
$361.0M
$354.1M
Treasury stock (4,776,918 and 4,594,943 shares at cost, respectively)
-115.2M
-93.0M
-94.3M
-95.4M
Retained earnings
$1.1B
$1.0B
$1.0B
$924.2M
Accumulated other comprehensive loss
($34.7M)
($91.0M)
($148.1M)
($145.2M)
Total Innospec stockholders' equity
$1.3B
$1.2B
$1.1B
$1.0B
Non-controlling interest
$6.8M
$4.9M
$2.5M
$2.4M
Total equity
$1.3B
$1.2B
$1.1B
$1.0B
Total liabilities and equity
$1.8B
$1.7B
$1.7B
$1.6B
Innospec Inc balance sheet, quarters
Line item
Jun 30, 2026
Mar 31, 2026
Sep 30, 2025
Jun 30, 2025
Cash and cash equivalents
$250.2M
$289.1M
$270.8M
$266.6M
Trade and other accounts receivable (less allowances of $15.4 million and $11.8 million respectively)
$408.6M
$354.2M
$349.5M
$336.1M
Finished goods
$235.0M
$225.6M
$236.3M
$235.2M
Raw materials
$102.3M
$95.9M
$108.9M
$101.6M
Total inventories
$337.3M
$321.5M
$345.2M
$336.8M
Prepaid expenses
$13.3M
$16.9M
$8.7M
$13.7M
Prepaid income taxes
$5.7M
$10.6M
$10.5M
$12.1M
Other current assets
$9.6M
$6.8M
$4.1M
$4.4M
Total current assets
$1.0B
$999.1M
$988.8M
$969.7M
Net property, plant and equipment
$293.3M
$285.7M
$278.6M
$295.8M
Operating lease right-of-use assets
$47.9M
$50.6M
$49.0M
$49.3M
Goodwill
$398.2M
$399.1M
$399.8M
$397.6M
Other intangible assets
$65.3M
$68.9M
$63.3M
$78.3M
Deferred tax assets
$13.3M
$13.0M
$8.9M
$8.9M
Other non-current assets
$3.5M
$3.4M
$11.0M
$6.5M
Total assets
$1.8B
$1.8B
$1.8B
$1.8B
Accounts payable
$169.4M
$138.5M
$162.2M
$149.4M
Accrued liabilities
$170.0M
$169.3M
$167.3M
$163.5M
Current portion of operating lease liabilities
$14.3M
$15.1M
$16.0M
$15.6M
Current portion of plant closure provisions
$4.9M
$4.9M
$5.0M
$5.0M
Current portion of acquisition-related contingent consideration
$2.8M
$2.7M
—
—
Accrued income taxes
$6.7M
$4.3M
$5.6M
$3.9M
Total current liabilities
$368.1M
$334.8M
$356.1M
$337.4M
Operating lease liabilities, net of current portion
$33.6M
$35.5M
$33.0M
$33.7M
Plant closure provisions, net of current portion
$59.8M
$60.8M
$63.2M
$63.8M
Deferred tax liabilities
$16.0M
$17.9M
$14.1M
$24.0M
Pension liabilities and post-employment benefits
$12.7M
$12.8M
$13.8M
$13.9M
Acquisition-related contingent consideration
$1.3M
$1.3M
$8.2M
$24.5M
Other non-current liabilities
$3.7M
$4.5M
$8.1M
$7.3M
Total liabilities
$495.2M
$467.6M
$496.5M
$504.6M
Common stock, $0.01 par value, authorized 40,000,000 shares, issued 29,554,500shares
300.0K
300.0K
300.0K
300.0K
Additional paid-in capital
$379.1M
$377.3M
$373.6M
$372.7M
Treasury stock (4,923,453 and 4,776,918 shares at cost, respectively)
-127.8M
-121.4M
-115.3M
-104.7M
Retained earnings
$1.1B
$1.1B
$1.1B
$1.1B
Accumulated other comprehensive loss
($45.9M)
($40.8M)
($35.0M)
($33.4M)
Total Innospec stockholders' equity
$1.3B
$1.3B
$1.3B
$1.3B
Non-controlling interest
$7.6M
$7.2M
$5.9M
$6.1M
Total equity
$1.4B
$1.4B
$1.3B
$1.3B
Total liabilities and equity
$1.8B
$1.8B
$1.8B
$1.8B
Cash flow statement
Innospec Inc cash flow statement, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Net income
$116.6M
$35.6M
$139.1M
$133.0M
Depreciation and amortization
$43.6M
$43.5M
$39.3M
$40.1M
Adjustment to fair value of contingent consideration
($15.9M)
$3.4M
—
—
Impairment of property, plant and equipment
$22.9M
—
—
—
Impairment of intangible assets
$19.1M
—
—
$0
Deferred taxes
($10.2M)
($39.3M)
$3.6M
($5.5M)
Profit on disposal of property, plant and equipment
($200.0K)
($200.0K)
—
—
Non-cash movements of defined benefit pension plans
$2.7M
—
—
—
Stock option compensation
$8.1M
$8.5M
$8.0M
$6.7M
Trade and other accounts receivable
$21.6M
$4.3M
($12.6M)
($55.5M)
Inventories
($6.6M)
($11.8M)
$83.0M
($98.5M)
Prepaid expenses
$1.8M
($2.8M)
($4.2M)
$4.6M
Accounts payable and accrued liabilities
($32.8M)
($4.5M)
($26.9M)
$54.2M
Plant closure provisions
($1.9M)
$900.0K
$4.0M
$1.1M
Accrued income taxes
($21.8M)
$6.3M
($25.9M)
$9.4M
Unrecognized tax benefits
$0
($14.8M)
$1.4M
($2.9M)
Other assets and liabilities
($8.7M)
$3.5M
$1.8M
($2.5M)
Net cash provided by operating activities
$138.3M
$184.5M
$207.3M
$81.7M
Capital expenditures
($50.3M)
($41.4M)
($62.1M)
($39.6M)
Proceeds on disposal of property, plant and equipment
$1.1M
$500.0K
$100.0K
$200.0K
Business combinations, net of cash acquired
($700.0K)
($200.0K)
($34.7M)
—
Internally developed software
($25.2M)
($20.9M)
($15.1M)
($2.7M)
Net cash used in investing activities
($75.1M)
($62.0M)
($111.8M)
($42.1M)
Non-controlling interest
$1.9M
$2.4M
$0
$1.8M
Repayment of term loan
$0
$0
($2.3M)
—
Refinancing costs
$0
($300.0K)
($1.4M)
$0
Dividend paid
($42.4M)
($38.8M)
($35.1M)
($31.7M)
Issue of treasury stock
$500.0K
$2.1M
$900.0K
$2.2M
Repurchase of common stock
($23.9M)
($700.0K)
($1.1M)
($5.9M)
Net cash used in financing activities
($63.9M)
($35.3M)
($39.0M)
($33.7M)
Effect of foreign currency exchange rate changes on cash
$4.0M
($1.7M)
$100.0K
($600.0K)
Net change in cash and cash equivalents
$3.3M
$85.5M
$56.6M
$5.3M
Cash and cash equivalents at beginning of year
$289.2M
$203.7M
$147.1M
$141.8M
Cash and cash equivalents at end of year
$292.5M
$289.2M
$203.7M
$147.1M
Innospec Inc cash flow statement, quarters
Line item
Jun 30, 2026 · YTD
Mar 31, 2026 · Q1
Sep 30, 2025 · YTD
Jun 30, 2025 · YTD
Net income
$62.0M
$30.4M
$69.2M
$56.3M
Depreciation and amortization
$19.9M
$9.9M
$34.2M
$22.0M
Adjustment to fair value of contingent consideration
($4.6M)
($4.7M)
($14.9M)
$1.5M
Deferred taxes
($2.7M)
($700.0K)
($10.6M)
($600.0K)
Profit on disposal of property, plant and equipment
$0
$0
($200.0K)
($200.0K)
Movements on defined benefit pension plans
$100.0K
($200.0K)
—
—
Stock option compensation
$3.8M
$1.6M
$5.0M
$4.1M
Trade and other accounts receivable
($70.2M)
($13.7M)
$14.7M
$28.9M
Inventories
($12.0M)
$5.9M
($22.2M)
($13.3M)
Prepaid expenses
$6.7M
$3.2M
$13.2M
$8.3M
Accounts payable and accrued liabilities
$14.6M
($17.7M)
($30.1M)
($46.5M)
Plant closure provisions
$1.1M
$1.5M
$1.1M
$1.4M
Income taxes
$7.2M
$400.0K
($19.9M)
($22.9M)
Other assets and liabilities
($1.1M)
$1.7M
($7.2M)
($4.0M)
Net cash provided by operating activities
$24.8M
$17.6M
$76.9M
$37.6M
Capital expenditures
($26.6M)
($8.9M)
($35.7M)
($21.4M)
Internally developed software
($5.1M)
($5.1M)
($18.6M)
($10.8M)
Proceeds on disposal of property, plant and equipment
$1.5M
$300.0K
$400.0K
$500.0K
Net cash used in investing activities
($30.2M)
($13.7M)
($55.9M)
($31.7M)
Dividend paid
($22.7M)
—
($20.8M)
($20.8M)
Issue of treasury stock
$100.0K
$100.0K
$400.0K
$400.0K
Repurchase of common stock
($13.5M)
($7.1M)
($23.9M)
($13.3M)
Net cash used in financing activities
($36.1M)
($6.6M)
($43.3M)
($32.5M)
Effect of foreign currency exchange rate changes on cash